⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9673094 | 0.81 | — | — | |
| SCHEMBL23234265 | 0.81 | MEN1 (0.41) | — | |
| SCHEMBL27694695 | 0.71 | MEN1 (0.35) | — | |
| Butane SCHEMBL27616613 | 0.69 | MEN1 (0.33) | — | |
| SCHEMBL10017669 | 0.61 | — | — | |
| SCHEMBL4216460 | 0.59 | — | — | |
| SCHEMBL11255228 | 0.57 | — | — | |
| SCHEMBL15789299 | 0.57 | — | — | |
| SCHEMBL1752289 | 0.57 | — | — | |
| SCHEMBL11843672 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 524 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113979887-A | Synthetic method of aromatic amine carboxylic acid derivative | 北京亦农生物科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| US-8344102-B2 | Nanoparticle and magnetic resonance imaging contrast agent | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2013-01-01 | — | — | US | claimed |
| EP-1806586-B1 | Mass labels | ELECTROPHORETICS LTD (GB) | 2012-08-15 | — | — | EP | claimed |
| US-20110092672-A1 | NANOPARTICLE AND MAGNETIC RESONANCE IMAGING CONTRAST AGENT | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2011-04-21 | — | — | US | claimed |
| US-7879852-B2 | such as (4S)-1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-yl]carbonyl}-4-[(4,4-dimethylcyclohexyl)(2,2-dimethylpropanoyl)amino]-N,N-dimethyl-L-prolineamide, used for the treatment of obesity, diabetes, inflammation and erectile dysfunction | LG LIFE SCIENCES LTD. (KR) | 2011-02-01 | — | — | US | claimed |
| US-20090298829-A1 | MELANOCORTIN RECEPTOR AGONISTS | LG LIFE SCIENCES LTD. (KR) | 2009-12-03 | — | — | US | claimed |
| EP-2124946-A1 | THE USE OF QUATERNARY PYRIDINIUM COMPOUNDS FOR VASOPROTECTION AND/OR HEPATOPROTECTION | Trigendo Sp. Z O.o. (PL) | 2009-12-02 | — | — | EP | claimed |
| WO-2008007930-A9 | MELANOCORTIN RECEPTOR AGONISTS | LG LIFE SCIENCES LTD (KR) | 2009-04-02 | — | — | WO | claimed |
| EP-2041120-A1 | MELANOCORTIN RECEPTOR AGONISTS | LG Life Sciences Ltd. (KR) | 2009-04-01 | — | — | EP | claimed |
| WO-2008104920-A1 | THE USE OF QUATERNARY PYRIDINIUM COMPOUNDS FOR VASOPROTECTION AND/OR HEPATOPROTECTION | TRIGENDO SP. Z O.O. (PL) | 2008-09-04 | — | — | WO | claimed |
| EP-0645379-B1 | Benzoylacetylene derivatives | MITSUBISHI CHEM CORP (JP) | 1999-03-17 | — | — | EP | claimed |
| WO-1999006434-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | claimed |
| WO-1999006433-A1 | COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| WO-1999006435-A1 | DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| WO-1999006390-A1 | CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| EP-0645379-A2 | Benzoylacetylene derivatives | Mitsubishi Chemical Corporation (JP) | 1995-03-29 | — | — | EP | claimed |
| EP-0189287-B1 | NOVEL B-LACTAM ANTIBIOTICS | NIPPON PHARMACEUTICAL DEVELOPMENT INSTITUTE COMPANY LIMITED (JP) | 1992-12-16 | — | — | EP | claimed |
| WO-1992003732-A2 | COMPOSITIONS AND METHODS FOR ENHANCED BINDING IN BIOLOGICAL ASSAYS | BIOPROBE INTERNATIONAL, INC. (US) | 1992-03-05 | — | — | WO | claimed |
| US-4808711-A | EFFECTIVE AGAINST PSEUDOMONAS AERUGINOSA | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1989-02-28 | — | — | US | claimed |
| EP-0189287-A2 | Novel B-lactam antibiotics | NIPPON PHARMACEUTICAL DEVELOPMENT INSTITUTE COMPANY LIMITED (JP) | 1986-07-30 | — | — | EP | claimed |